153 related articles for article (PubMed ID: 11578778)
1. Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses.
LaDu MJ; Shah JA; Reardon CA; Getz GS; Bu G; Hu J; Guo L; Van Eldik LJ
Neurochem Int; 2001; 39(5-6):427-34. PubMed ID: 11578778
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures.
LaDu MJ; Shah JA; Reardon CA; Getz GS; Bu G; Hu J; Guo L; van Eldik LJ
J Biol Chem; 2000 Oct; 275(43):33974-80. PubMed ID: 10940295
[TBL] [Abstract][Full Text] [Related]
3. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.
Guo L; LaDu MJ; Van Eldik LJ
J Mol Neurosci; 2004; 23(3):205-12. PubMed ID: 15181248
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease.
Holtzman DM; Herz J; Bu G
Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a006312. PubMed ID: 22393530
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation.
Hu J; LaDu MJ; Van Eldik LJ
J Neurochem; 1998 Oct; 71(4):1626-34. PubMed ID: 9751196
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease.
Laskowitz DT; Fillit H; Yeung N; Toku K; Vitek MP
Acta Neurol Scand Suppl; 2006; 185():15-20. PubMed ID: 16866906
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1.
Hayashi H; Campenot RB; Vance DE; Vance JE
J Neurosci; 2007 Feb; 27(8):1933-41. PubMed ID: 17314289
[TBL] [Abstract][Full Text] [Related]
8. The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain.
Domenger D; Dea D; Theroux L; Moquin L; Gratton A; Poirier J
Exp Neurol; 2012 Jan; 233(1):513-22. PubMed ID: 22155743
[TBL] [Abstract][Full Text] [Related]
9. Iron Regulates Apolipoprotein E Expression and Secretion in Neurons and Astrocytes.
Xu H; Perreau VM; Dent KA; Bush AI; Finkelstein DI; Adlard PA
J Alzheimers Dis; 2016; 51(2):471-87. PubMed ID: 26890748
[TBL] [Abstract][Full Text] [Related]
10. Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein.
Narita M; Holtzman DM; Fagan AM; LaDu MJ; Yu L; Han X; Gross RW; Bu G; Schwartz AL
J Biochem; 2002 Nov; 132(5):743-9. PubMed ID: 12417024
[TBL] [Abstract][Full Text] [Related]
11. Similar activation of glial cultures from different rat brain regions by neuroinflammatory stimuli and downregulation of the activation by a new class of small molecule ligands.
Guo L; Sawkar A; Zasadzki M; Watterson DM; Van Eldik LJ
Neurobiol Aging; 2001; 22(6):975-81. PubMed ID: 11755006
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.
Poirier J
Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807
[TBL] [Abstract][Full Text] [Related]
13. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
[TBL] [Abstract][Full Text] [Related]
14. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E.
Umans L; Overbergh L; Serneels L; Tesseur I; Van Leuven F
Biol Reprod; 1999 Nov; 61(5):1216-25. PubMed ID: 10529267
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms.
Strittmatter WJ
Biochem Soc Symp; 2001; (67):101-9. PubMed ID: 11447826
[TBL] [Abstract][Full Text] [Related]
16. Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
Irizarry MC; Rebeck GW; Cheung B; Bales K; Paul SM; Holzman D; Hyman BT
Ann N Y Acad Sci; 2000; 920():171-8. PubMed ID: 11193147
[TBL] [Abstract][Full Text] [Related]
17. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals.
Gylys KH; Fein JA; Tan AM; Cole GM
J Neurochem; 2003 Mar; 84(6):1442-51. PubMed ID: 12614344
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway.
Wilsie LC; Gonzales AM; Orlando RA
Lipids Health Dis; 2006 Aug; 5():23. PubMed ID: 16945147
[TBL] [Abstract][Full Text] [Related]
20. Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide.
Saura J; Petegnief V; Wu X; Liang Y; Paul SM
J Neurochem; 2003 Jun; 85(6):1455-67. PubMed ID: 12787065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
